Industry regulation and firm innovation: Evidence from national centralized drug procurement policy in China
Economic Analysis and Policy · 2026-01 · 89 · 421-441
DOI: 10.1016/j.eap.2025.12.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Economic Analysis and Policy, 2026-01. Verfasst von Siyu Zhang und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 99 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Science and Technology Planning Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- National Science and Technology Planning Project
Zitieren
APA
Zhang, S., Huang, Y., & Luo, D. (2026). Industry regulation and firm innovation: Evidence from national centralized drug procurement policy in China. Economic Analysis and Policy, 89, 421-441. https://doi.org/10.1016/j.eap.2025.12.013
Vancouver
Zhang S, Huang Y, Luo D. Industry regulation and firm innovation: Evidence from national centralized drug procurement policy in China. Economic Analysis and Policy. 2026;89:421-441. doi:10.1016/j.eap.2025.12.013
BibTeX
@article{Zhang2026,
author = {Zhang, Siyu and Huang, Yuexin and Luo, Danglun},
title = {Industry regulation and firm innovation: Evidence from national centralized drug procurement policy in China},
journal = {Economic Analysis and Policy},
year = {2026},
volume = {89},
pages = {421--441},
doi = {10.1016/j.eap.2025.12.013}
}
EUVIMED